Apolipoprotein E and Atherosclerosis

Area of Science:

• Lipidology
• Genetics
• Clinical Medicine

Background:

• Apolipoprotein E (APOE) plays a crucial role in lipoprotein metabolism and cardiovascular health.
• APOE genetic variations are linked to various dyslipidemias, including dysbetalipoproteinemia and moderate dyslipidemia.
• APOE influences inflammation and has implications for cognitive function.

Purpose of the Study:

• To review the functions, genetic variations, and clinical impact of apolipoprotein E on lipoprotein metabolism.
• To contextualize APOE's role in clinical practice for dyslipidemias and related disorders.
• To explore the association of APOE with atherosclerosis, inflammation, and cognitive impairment.

Main Methods:

• Literature review focusing on apolipoprotein E functions, genetic variations, and clinical implications.
• Analysis of studies investigating APOE's role in lipoprotein metabolism, dyslipidemias, and atherosclerosis.
• Examination of research on APOE variants, inflammation, and cognitive function.

Main Results:

• APOE genetic variations significantly affect lipoprotein metabolism and lipid profiles.
• APOE2 generally has favorable effects, while APOE4 is atherogenic and associated with cognitive impairment.
• Dysbetalipoproteinemia, an extreme form of remnant lipoprotein accumulation, is linked to atherosclerosis and glomerulopathy.

Conclusions:

• Apolipoprotein E is a key determinant of lipid profiles and cardiovascular health.
• Understanding APOE polymorphisms can enhance medical care for patients with dyslipidemias and related conditions.
• Mimetic peptides targeting APOE pathways may offer novel therapeutic strategies.